VEGF Gene Therapy Improves Exercise Time, Ischemia, and Symptoms in Patients with Refractory Angina: Results of the Phase II EXACT Trial
Kenta Nakamura, M.D., FSCAI1, Timothy D. Henry, M.D., MSCAI2, Jay H. Traverse, M.D., FSCAI3, David A Latter, MD4, Nahush A Mokadam, MD5, Geoffrey A Answini, MD6, Adam R Williams, MD7, Benjamin Sun, M.D.8, Christopher R Burke, M.D.9, Faisal G Bakaeen, M.D.10, Marcelo F DiCarli, M.D.11, Bernard R. Chaitman, M.D.12, Mark W Peterson, B.A.13, Dawn G Byrnes, M.Sc.13, E. M. Ohman, M.D.14, Carl J. Pepine, M.D.15, Ronald G Crystal, M.D.16, Todd K Rosengart, M.D.17, Elaine Kowalewski, Ph.D.18, Gary G Koch, Ph.D.18, Howard C Dittrich, M.D.13 and Thomas Joseph Povsic, M.D., Ph.D., FSCAI19, (1)The University of Washington School of Medicine, Seattle, WA, (2)The Christ Hospital Health Network, Covington, KY, (3)Minneapolis Heart Institute® - Abbott Northwestern Hospital, Minneapolis, MN, (4)Department of Cardiovascular Surgery, St. Michael's Hospital, University of Toronto, Canada, Toronto, ON, Canada, (5)Wexner Medical Center, Ohio State University, Columbus, OH, (6)The Christ Hospital Health Network, Cincinnati, OH, (7)Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University, Durham, NC, (8)Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN, (9)The University of Washington, Seattle, WA, (10)Cleveland Clinic Foundation, Cleveland, OH, (11)Brigham and Women's Hospital, Boston, MA, (12)Saint Louis University School of Medicine, St. Louis, MO, (13)XyloCor Therapeutics, Malvern, PA, (14)Duke University Medical Center, Durham, NC, (15)University of Florida College of Medicine Gainesville, Gainesville, FL, (16)Weill Cornell Medical College, New York, NY, (17)Baylor College of Medicine, Houston, TX, (18)University of North Carolina, Chapel Hill, NC, (19)Duke Clinical Research Institute, Chapel Hill, NC